Helix BioMedix, Inc. (HXBM)
OTCMKTS · Delayed Price · Currency is USD
1.790
+0.090 (5.29%)
At close: May 4, 2026
Helix BioMedix Market Cap
Helix BioMedix has a market cap or net worth of $402.23 thousand as of May 5, 2026. Its market cap has decreased by -97.30% in one year.
Market Cap
402.23K
Enterprise Value
n/a
Revenue
2.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.79
Market Cap Chart
Since July 26, 1995, Helix BioMedix's market cap has decreased from 1.59M to 402.23K, a decrease of -74.78%. That is a compound annual growth rate of -4.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 402.23K | -10.50% |
| Dec 31, 2025 | 449.42K | -75.00% |
| Dec 26, 2024 | 1.80M | -76.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aibotics | 785.99K |
| SQZ Biotechnologies Company | 710.74K |
| Halberd | 709.94K |
| Emmaus Life Sciences | 617.66K |
| Bio-Path Holdings | 584.59K |
| Regenerative Medical Technology Group | 512.42K |
| Altamira Therapeutics | 457.24K |
| Actavia Life Sciences | 385.91K |